| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: BPUR |
| Security Type |
Class A Common Shares |
| Lead Underwriter |
JP Morgan |
| Days In Registration |
72 |
| Date Filed |
19-May-1999 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
Biopure Corp, located in Cambridge, Massachusetts, is a manufacturer and wholesaler of oxygen therapeutics. Its products include Hemopur for human use that treats cardiovascular ischemia, and Oxyglobin used for the treatment of anemia in dogs. The company was founded in 1984. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
- |
| Contact |
Jane Kober, Esq. |
| Number of Employees |
203 |
|
| Original Filing Information |
| US |
| Shares Filed |
4.5M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
4.5M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
525.0K |
| File Amount |
$74.25M |
| File Price Range |
$17.50 - $15.50 |
| File Mid Price |
$16.50 |
Current Filing Information
(Amended 29-Jul-1999) |
|
US |
|
Shares Filed |
3.5M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
3.5M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$45.5M |
| · % Change from Original |
-38.72 |
| File Price Range |
$14.00 - $12.00 |
| File Mid Price |
$13.00 |
|
